Return to the fetal gene program: A suggested metabolic link to gene expression in the heart

Annals of the New York Academy of Sciences

Volumn 1188, Issue , 2010, Pages 191-198

  Taegtmeyer, Heinrich ^a   Sen, Shiraj ^a   Vela, Deborah ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Atrophy; Fetal heart; Glucose; Heart failure; Hibernating myocardium; Hypertrophy; Metabolism

Indexed keywords

CARBOHYDRATE; CONTRACTILE PROTEIN; TRANSCRIPTION FACTOR;

ATROPHY; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; DIABETES MELLITUS; FATTY ACID OXIDATION; FETUS HEART; FUNCTIONAL DISEASE; GENE EXPRESSION; GLYCOSYLATION; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART STRESS; HEART VENTRICLE REMODELING; HYPOTHYROIDISM; PATHOPHYSIOLOGY; SARCOMERE;

EID: 77649087980     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05100.x     Document Type: Conference Paper

References (46)

1. Rajabi, M. et al. 2007. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12: 331-343.
2. Bartelds, B. et al. 2000. Perinatal changes in myocardial metabolism in lambs. Circulation 102: 926-931.
3. Goodwin, G. W., C.S. Taylor & H. Taegtmeyer. 1998. Reg-ulation of energy metabolism of the heart during acute increase in heart work. J. Biol. Chem. 273: 29530-29539.
4. Smith, R. 2007. Parturition. N. Engl. J. Med. 356: 271-283.
5. Navaratnam, V. 1987. Heart Muscle: Ultrastructural Stud-ies. Cambridge University Press. New York.
6. Pederson, B.A. et al. 2004. Abnormal cardiac development in the absence of heart glycogen. Mol. Cell. Biol. 24: 7179-7187.
7. Scholz, T.D. et al. 1998. Ontogeny of malate-aspartate shuttle capacity and gene expression in cardiac mitochondria. Am. J. Physiol. 274: C780-C788.
8. Lehman, J.J. et al. 2000. Peroxisome proliferatoractivated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106: 847-856.
9. Girard, J. et al. 1992. Adaptations of glucose and fatty acid metabolism during perinatal period and sucklingweaning transition. Physiol. Rev. 72: 507-562.
10. Sassoon, D.A., I. Garner & M. Buckingham. 1988. Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo. Development 104: 155-164.
11. Schwartz, K. et al. 1992. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am. J. Physiol. 262: R364-R369.
12. Everett, A. W. 1986. Isomyosin expression in human heart in early pre- and post-natal life. J. Mol. Cell. Cardiol. 18: 607-615.
13. Morkin,E.1993.Regulationofmyosinheavychaingenesintheheart.Circulation87: 1451-1460.(Pubitemid23133087)
14. Razeghi, P. et al. 2001. Metabolic gene expression in fetal and failing human heart. Circulation 104: 2923-2931.
15. Lahmers, S. et al. 2004. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ. Res. 94: 505-513. (Pubitemid 38326286) (Pubitemid 38326286)
16. Neagoe, C. et al. 2002. Titin isoform switch in ischemic human heart disease. Circulation 106: 1333-1341. (Pubitemid 35013035) (Pubitemid 35013035)
17. Akazawa, H. & I. Komuro. 2003. Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 92: 1079-1088. (Pubitemid 36665853) (Pubitemid 36665853)
18. Morkin, E. 2000. Control of cardiac myosin heavy chain gene expression. Microsc. Res. Tech. 50: 522-531.
19. van Rooij, E., N. Liu & E.N. Olson. 2008. MicroRNAs flex their muscles. Trends Genet. 24: 159-166.
20. Clark, R.J. et al. 2003. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278: 44230-44237.
21. Young, M.E. et al. 2007. Proposed regulation of gene expression by glucose in rodent heart. Gene Reg. Systems Biol. 1: 251-262.
22. Sack, M.N. et al. 1997. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc. Natl. Acad. Sci. USA 94: 6438-6443.
23. Taegtmeyer, H. 1994. Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Prob. Cardiol. 19: 57-116.
24. Uyeda, K. & J.J. Repa. 2006. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4: 107-110.
25. Dawes, G.S., J.C. Mott & H.J. Shelley. 1959. The importance of cardiac glycogen for the maintenance of life in foetal lambs and newborn animals during anoxia. J. Physiol. (Lond.) 146: 516-538.
26. Taegtmeyer, H. 2004. Glycogen in the heart: an expanded view. J. Mol. Cell. Cardiol. 37: 7-10.
27. Razeghi, P. et al. 2001. Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. Biochem. Biophys. Res. Commun. 287: 5-10.
28. Sharma, S. et al. 2004. Dynamic changes of gene expression in hypoxia-induced right ventricular hypertrophy. Am. J. Cardiol. Heart Circ. Physiol. 286: H1185-H1192.
29. Depre, C. et al. 2000. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J. Mol. Cell. Cardiol. 32: 985-996. (Pubitemid 30663106) (Pubitemid 30663106)
30. Young, M.E. et al. 2002. Alterations of the circadian clock in the heart by streptozotocin-induced diabetes. J. Mol. Cell. Cardiol. 34: 223-231. (Pubitemid 35222831) (Pubitemid 35222831)
31. Razeghi, P. et al. 2002. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation 106: 407-411. (Pubitemid 34803682) (Pubitemid 34803682)
32. Kurabayashi,M.etal.1988. Molecularcloningandcharacterizationofhumancardiacalpha-andbeta- formmyosinheavychaincomplementaryDNAclones: regulationofexpressionduringdevelopmentandpressureoverloadinhumanatrium.J.Clin. Invest.82:524-531.(Pubitemid18213753)
33. Reiser, P.J. et al. 2001. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am. J. Physiol. Heart Circ. Physiol. 280: H1814-H1820.
34. Nakao,K.etal.1997.Myosinheavychaingeneexpressioninhumanheartfailure.J. Clin.Invest.100:2362-2370.(Pubitemid27500161)
35. Chess, D.J. & W.C. Stanley. 2008. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc. Res. 79: 269-278.
36. Heusch, G., R. Schulz & S.H. Rahimtoola. 2005. Myocardial hibernation: a delicate balance. Am. J. Physiol. Heart Circ. Physiol. 288: H984-H999.
37. Sack, M.N. & D M. Yellon. 2003. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia. A proposed direct myocardial cell survival effect independent of metabolic modulation. J. Am. Coll. Cardiol. 41: 1404-1407.
38. Jonassen, A.K., O.D. Mjos & M.N. Sack. 2004. p70s6 kinase is a functional target of insulin activated Akt cellsurvival signaling. Biochem. Biophys. Res. Commun. 315: 160-165.
39. Matsui, T., T. Nagoshi & A. Rosenzweig. 2003. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2: 220-223.
40. Whiteman, E., H. Cho & M. Birnbaum. 2002. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13: 444-1151
41. Gottlob, K. et al. 2001. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15: 1406-1418.
42. Cook, S.A. et al. 2002. Transcriptional effects of chronic Akt activation in the heart. J. Biol. Chem. 277: 22528-22533.
43. Dewald, O. et al. 2005. Downregulation of peroxisome proliferator- activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 112: 407-415.
44. Depre, C. et al. 1998. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Not. Med. 4: 1269-1275.
45. Eichhorn, E.J. & M.R. Bristow. 1996. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94: 2285-2296.
46. Young, M.E., P. McNulty & H. Taegtmeyer. 2002. Adaptation and maladaptation of the heart in diabetes: Part II. Potential mechanisms. Circulation 105: 1861-1870. (Pubitemid 34408899) (Pubitemid 34408899)